HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Use of rheogluman in the acute period of myocardial infarction].

Abstract
The efficacy of rheogluman was evaluated in 55 patients with acute myocardial infarction. ECG mapping recordings in 35 leads showed that an earlier positive dynamics in sigma ST, sigma Q, and sigma R was significantly observed in patients treated with rheogluman than in untreated patients. These data indirectly indicated a reduction in the ++peri-infarct zone in the acute period of myocardial infarction. The serum concentrations of lysosomal enzymes (creatine phosphokinase, lactate dehydrogenase, aspartate aminotransferase, alanine amino-transferase) became normal earlier in the rheogluman-treated patients than in the controls. This fact may be regarded as a protective effect of the drug on the formation of a necrotic focus.
AuthorsIa Z Kurbanov, Ia D Mamedov, Sh G Garaev, D N Kerimova
JournalKardiologiia (Kardiologiia) Vol. 32 Issue 3 Pg. 72-4 (Mar 1992) ISSN: 0022-9040 [Print] Russia (Federation)
Vernacular TitlePrimenenie reogliumana v ostrom periode infarkta miokarda.
PMID1383592 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Dextrans
  • Drug Combinations
  • Plasma Substitutes
  • Solutions
  • rheogluman
  • Mannitol
  • Sodium Chloride
Topics
  • Adult
  • Aged
  • Dextrans (administration & dosage)
  • Drug Combinations
  • Electrocardiography, Ambulatory
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Mannitol (administration & dosage)
  • Middle Aged
  • Myocardial Infarction (diagnosis, drug therapy)
  • Plasma Substitutes (administration & dosage)
  • Sodium Chloride (administration & dosage)
  • Solutions

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: